XML 46 R35.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
SCHEDULE OF CASH AND CASH EQUIVALENTS AND INVESTMENTS (Details) - USD ($)
9 Months Ended 12 Months Ended
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Impairment Effects on Earnings Per Share [Line Items]      
Cash and Cash Equivalents $ 4,285,343 $ 5,619,083 $ 6,048,001
Cash [Member]      
Impairment Effects on Earnings Per Share [Line Items]      
Cost 171,727 242,271  
Unrealized Gain (Loss)  
Cash and Cash Equivalents 171,727 242,271  
Money Market Funds [Member] | Fair Value, Inputs, Level 1 [Member]      
Impairment Effects on Earnings Per Share [Line Items]      
Cost 4,113,616 5,376,812  
Unrealized Gain (Loss)  
Cash and Cash Equivalents 4,113,616 5,376,812  
Fair Value 4,113,616 5,376,812  
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 1 [Member]      
Impairment Effects on Earnings Per Share [Line Items]      
Cost 4,285,343 5,619,083  
Unrealized Gain (Loss)  
Cash and Cash Equivalents 4,285,343 5,619,083  
Fair Value $ 4,113,616 $ 5,376,812